BERLIN, Nov 9 (Reuters) - Data from Pfizer and its partner BioNTech on their experimental COVID-19 vaccine are encouraging, Germany’s health minister said on Monday.
“If this should prove true ... then it would be a good signal because it shows that this vaccine makes a difference,” Spahn told a news conference. “This is encouraging.”
The two companies earlier on Monday became the first drugmakers to release successful trial data, saying their vaccine was shown to be more than 90% effective, a major victory in the fight against the pandemic. (Reporting by Caroline Copley; editing by Thomas Seythal)
Our Standards: The Thomson Reuters Trust Principles.